Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Background and rationale: Inhaled nitric oxide (iNO) is recommended for the treatment of severe persistent pulmonary hypertension of the newborn (PPHN) because it reduces the need for extracorporeal membrane oxygenation (ECMO). There is insufficient evidence that iNO reduces mortality in the absence...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Neonatology
2019
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|